Treatment for reactive arthritis or bursitis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/65 (2006.01) A61K 31/415 (2006.01) A61K 31/519 (2006.01)

Patent

CA 2502397

A pharmaceutical formulation for treating conditions in human beings associated with either or both reactive arthritis or bursitis comprising a combination of acyclovir, minocycline, hydrochloride, and metronidazole. An alternate treatment comprises the combination of valacyclovir hydrochloride , minocycline hydrochloride, and metronidazole.

L'invention concerne une formulation pharmaceutique pour le traitement d'affections humaines associées à l'arthrite ou à la bursite réactive, ou aux deux à la fois, qui renferme la combinaison suivante: acyclovir, hydrochlorure de minocycline, et métronidazole. En guise de variante, la combinaison peut être: hydrochlorure de valacyclovir, hydrochlorure de minocycline, et métronidazole.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment for reactive arthritis or bursitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for reactive arthritis or bursitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for reactive arthritis or bursitis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1346481

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.